The weekly litigation news digest is live. Subscribe now

Sant competitive analysis

Loading summary...

Explore patent oppositions filed by Sant against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Use Of Isoxazoline Compounds For Treating DemodicosisINTERVETOct 28, 2025
Method For Determining At Least One Parameter Associated With An Ophthalmic DeviceESSILORJan 31, 2025
A Shrinking MachineRED CARPETOct 17, 2024
Device For Supporting At Least One Arm Of A UserOTTOBOCKJun 26, 2024
Treatment Of Metabolic Disorders In Canine AnimalsBOEHRINGER INGELHEIMFeb 9, 2024
Device For Supporting At Least One Arm Of A UserOTTOBOCKDec 23, 2023
A Vaccine For Protection Against Streptococcus SuisINTERVETSep 19, 2023
Porcine Circovirus Type 2 (Pcv2) Subunit VaccineBOEHRINGER INGELHEIMJul 26, 2023
Atropine-Containing Aqueous CompositionNANYANG TECHNOLOGICAL UNIVERSITYMay 31, 2023
Isoxazoline Compositions And Their Use As Antiparasitics For FelinesINTERVETFeb 11, 2022

Explore Sant's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
Aug 31, 2022Atropine-Containing Aqueous Composition2
Jan 26, 2022Method And Composition For Treating Ocular Hypertension And Glaucoma3
Apr 29, 2020Method And Composition For Treating Ocular Hypertension And Glaucoma1
Feb 12, 2020Antisense Design1
May 3, 2017Method And Composition For Treating Ocular Hypertension And Glaucoma1

Latest PTAB cases involving Sant

Discover the latest PTAB cases involving Sant, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 20, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Sant

IPR2017-01434May 12, 2017MICRO LABSSANTEN PHARMACEUTICALFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Sant with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CEVA SANTE ANIMALE223 - -
BAYER ANIMAL HEALTH33 - -
BOEHRINGER INGELHEIM49179109
INTERVET113641